Skip to content

Clinical Trial to Evaluate Safety and Efficacy of Ultherapy™ System for Lifting Skin on the Neck

Clinical Trial to Evaluate Safety and Efficacy of Ultherapy™ System for Lifting Skin

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02368925
Enrollment
18
Registered
2015-02-23
Start date
2015-03-31
Completion date
2015-10-31
Last updated
2016-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wrinkles

Keywords

Rhytids, Skin Laxity

Brief summary

Study is a prospective clinical trial to evaluate the efficacy of the Ulthera® System to improve Lifting Skin on the Neck. Changes from baseline in the FACE-Q Appraisal of Neck scale score and Global Aesthetic Improvement Scale scores will be assessed at study follow-up visits.

Detailed description

Before Treatment: The subject's eligibility (inclusion/exclusion criteria) will be assessed, and all subjects will check the FACE-Q Appraisal of Neck scale score Treatment: The Investigator will apply to the eligible subject the Study Device Ultherapy™ System with 200\ 260 lines of 3.0 and 4.5 probe respectively on the subject's neck. Post-Treatment: All subjects will visit the Institution at 12 weeks from the day of procedure, and will take photos of the neck. Efficacy evaluation will performed by the Photographic Evaluator.

Interventions

The Investigator will apply to the eligible subject the Study Device Ultherapy™ System with 200\ 260 lines of 3.0 and 4.5 probe respectively on the subject's neck.

Sponsors

Ministry of Health & Welfare, Korea
CollaboratorOTHER_GOV
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female, aged 30 to 65 years. * Subject in good health * Subjects who desire improvement in neck skin

Exclusion criteria

* Presence of an active systemic infectious disease * general disease or skin disorder in the area to be treated * Pregnant or lactating subjects * Previous episode of facial or neck surgery for wrinkle correction * Subjects who have aesthetic addiction, drug abuse, alcohol abuse * Subjects who were treated Botox or Filler at the neck area * Subjects who had Auto-Immune disease

Design outcomes

Primary

MeasureTime frameDescription
Investigator Assessment of Improvement at 12 weeks post-treatment12 weeks post-treatmentInvestigator complete Global Aesthetic Improvement Scale at 12 weeks post-treatment by comparing subject's photographs

Secondary

MeasureTime frameDescription
Subject Assessment of Improvement at 12 weeks post-treatment12 weeks post-treatmentSubjects complete a Patient Assessment Global Aesthetic Improvement Scale at 12 weeks posttreatment
Subjects' Assessment of Pain during treatmentSubjects were assessed for the duration of study treatmentPain score record using a Numeric Rating Scale (NRS,0-10) , with 0 representing no pain and 10 representing the worst pain possible.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026